On Tuesday, August 29th, President Biden officially announced the first ten drugs that CMS has named eligible for Medicare negotiations. Once implemented, Medicare negotiations will save patients and taxpayers billions on prescriptions in Part D and ensure millions more people can access affordable medicines they need.  But even as Medicare officials prepare to negotiate prices, the drug corporations that manufacture these medicines are filing lawsuits to try and overturn the law so they can keep price-gouging patients and inflating profits. It’s time for Big Pharma to stop suing and start negotiating lower prices so everyone in Medicare can get the medicines they need.

The first 10 drugs are:

Jardiance (for type 2 diabetes)

Eliquis (for blood clots)

Xeralto (for blood clots)

Januvia (for type 2 diabetes)

Entresto (for heart failure)

Farsiga (for type 2 diabetes)

Imbruvica (for lymphoma)

Enbrel (for arthritis)

Stelara (for psoriasis)

Fiasp (for diabetes)